The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors.EBI
National Clinical Research Center for Geriatrics
Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?EBI
National Clinical Research Center For Geriatrics
Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.EBI
National Clinical Research Center For Geriatrics
Recent advances in the design and discovery of synthetic tyrosinase inhibitors.EBI
National Clinical Research Center For Geriatrics
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy.EBI
National Clinical Research Center For Geriatrics
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy.EBI
National Clinical Research Center For Geriatrics
Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases.EBI
National Clinical Research Center For Geriatrics
Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.EBI
National Clinical Research Center For Geriatrics